This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Steger, K. K.
Right arrow Articles by Pauza, C. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Steger, K. K.
Right arrow Articles by Pauza, C. D.

 Previous Article  |  Next Article 

J Virol, February 1998, p. 1600-1605, Vol. 72, No. 2
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

CD4+-T-Cell and CD20+-B-Cell Changes Predict Rapid Disease Progression after Simian-Human Immunodeficiency Virus Infection in Macaquesdagger

Krista K. Steger,1 Marta Dykhuizen,2 Jacque L. Mitchen,2 Paul W. Hinds,2 Brenda L. Preuninger,1 Marianne Wallace,1 James Thomson,2 David C. Montefiori,3 Yichen Lu,4 and C. David Pauza1,2,*

Department of Pathology and Laboratory Medicine, University of Wisconsin Medical School,1 and Wisconsin Regional Primate Research Center,2 Madison, Wisconsin 53706; Duke University, Durham, North Carolina 277103; and Institute for International Vaccine Development, Cambridge, Massachusetts 021384

Received 16 July 1997/Accepted 4 November 1997

Simian-human immunodeficiency virus 89.6PD (SHIV89.6PD) was pathogenic after intrarectal inoculation of rhesus macaques. Infection was achieved with a minimum of 2,500 tissue culture infectious doses of cell-free virus stock, and there was no evidence for transient viremia in animals receiving subinfectious doses by the intrarectal route. Some animals experienced rapid progression of disease characterized by loss of greater than 90% of circulating CD4+ T cells, sustained decreases in CD20+ B cells, failure to elicit virus-binding antibodies in plasma, and high levels of antigenemia. Slower-progressing animals had moderate but varying losses of CD4+ T cells; showed increases in circulating CD20+ B cells; mounted vigorous responses to antibodies in plasma, including neutralizing antibodies; and had low or undetectable levels of antigenemia. Rapid progression led to death within 30 weeks after intrarectal inoculation. Plasma antigenemia at 2 weeks after inoculation (P <=  0.002), B- and T-cell losses (P <=  0.013), and failure to seroconvert (P <=  0.005) were correlated statistically with rapid progression. Correlations were evident by 2 to 4 weeks after intrarectal SHIV inoculation, indicating that early events in the host-pathogen interaction determined the clinical outcome.


* Corresponding author. Mailing address: Department of Pathology and Laboratory Medicine, 1300 University Ave., Room 505, Service Memorial Institute, Madison, WI 53706. Phone: (608) 262-9147. Fax: (608) 262-9148. E-mail: cdpauza{at}facstaff.wisc.edu.

dagger Publication 37-030 from the Wisconsin Regional Primate Research Center.




This article has been cited by other articles:

  • Picker, L. J., Hagen, S. I., Lum, R., Reed-Inderbitzin, E. F., Daly, L. M., Sylwester, A. W., Walker, J. M., Siess, D. C., Piatak, M. Jr., Wang, C., Allison, D. B., Maino, V. C., Lifson, J. D., Kodama, T., Axthelm, M. K. (2004). Insufficient Production and Tissue Delivery of CD4+ Memory T Cells in Rapidly Progressive Simian Immunodeficiency Virus Infection. JEM 200: 1299-1314 [Abstract] [Full Text]  
  • Potula, R., Dhillion, N., Sui, Y., Zien, C. A., Funa, K., Pinson, D., Mayo, M. S., Singh, D. K., Narayan, O., Buch, S. (2004). Association of Platelet-Derived Growth Factor-B Chain with Simian Human Immunodeficiency Virus Encephalitis. Am. J. Pathol. 165: 815-824 [Abstract] [Full Text]  
  • Chen, Z., Huang, Y., Zhao, X., Skulsky, E., Lin, D., Ip, J., Gettie, A., Ho, D. D. (2000). Enhanced Infectivity of an R5-Tropic Simian/Human Immunodeficiency Virus Carrying Human Immunodeficiency Virus Type 1 Subtype C Envelope after Serial Passages in Pig-Tailed Macaques (Macaca nemestrina). J. Virol. 74: 6501-6510 [Abstract] [Full Text]  
  • Giavedoni, L. D., Velasquillo, M. C., Parodi, L. M., Hubbard, G. B., Hodara, V. L. (2000). Cytokine Expression, Natural Killer Cell Activation, and Phenotypic Changes in Lymphoid Cells from Rhesus Macaques during Acute Infection with Pathogenic Simian Immunodeficiency Virus. J. Virol. 74: 1648-1657 [Abstract] [Full Text]  
  • Crawford, J. M., Earl, P. L., Moss, B., Reimann, K. A., Wyand, M. S., Manson, K. H., Bilska, M., Zhou, J. T., Pauza, C. D., Parren, P. W. H. I., Burton, D. R., Sodroski, J. G., Letvin, N. L., Montefiori, D. C. (1999). Characterization of Primary Isolate-Like Variants of Simian-Human Immunodeficiency Virus. J. Virol. 73: 10199-10207 [Abstract] [Full Text]  
  • Wallace, M., Waterman, P. M., Mitchen, J. L., Djavani, M., Brown, C., Trivedi, P., Horejsh, D., Dykhuizen, M., Kitabwalla, M., Pauza, C. D. (1999). Lymphocyte Activation during Acute Simian/Human Immunodeficiency Virus SHIV89.6PD Infection in Macaques. J. Virol. 73: 10236-10244 [Abstract] [Full Text]  
  • Buge, S. L., Murty, L., Arora, K., Kalyanaraman, V. S., Markham, P. D., Richardson, E. S., Aldrich, K., Patterson, L. J., Miller, C. J., Cheng, S.-M., Robert-Guroff, M. (1999). Factors Associated with Slow Disease Progression in Macaques Immunized with an Adenovirus-Simian Immunodeficiency Virus (SIV) Envelope Priming-gp120 Boosting Regimen and Challenged Vaginally with SIVmac251. J. Virol. 73: 7430-7440 [Abstract] [Full Text]  
  • Gallo, R. C. (1999). Tat as one key to HIV-induced immune pathogenesis and Pat toxoid as an important component of a vaccine. Proc. Natl. Acad. Sci. USA 96: 8324-8326 [Full Text]  
  • Yin, C., Wu, M. S., Pauza, C. D., Salvato, M. S. (1999). High Major Histocompatibility Complex-Unrestricted Lysis of Simian Immunodeficiency Virus Envelope-Expressing Cells Predisposes Macaques to Rapid AIDS Progression. J. Virol. 73: 3692-3701 [Abstract] [Full Text]  
  • Mascola, J. R., Lewis, M. G., Stiegler, G., Harris, D., VanCott, T. C., Hayes, D., Louder, M. K., Brown, C. R., Sapan, C. V., Frankel, S. S., Lu, Y., Robb, M. L., Katinger, H., Birx, D. L. (1999). Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies. J. Virol. 73: 4009-4018 [Abstract] [Full Text]  
  • Shinohara, K, Sakai, K, Ando, S, Ami, Y, Yoshino, N, Takahasi, E, Someya, K, Suzaki, Y, Nakasone, T, Sasaki, Y, Kaizu, M, Lu, Y, Honda, M (1999). A highly pathogenic simian/human immunodeficiency virus with genetic changes in cynomolgus monkey. J. Gen. Virol. 80: 1231-1240 [Abstract]  
  • Steger, K. K., Waterman, P. M., Pauza, C. D. (1999). Acute Effects of Pathogenic Simian-Human Immunodeficiency Virus Challenge on Vaccine-Induced Cellular and Humoral Immune Responses to Gag in Rhesus Macaques. J. Virol. 73: 1853-1859 [Abstract] [Full Text]  
  • Lewis, M. G., Yalley-Ogunro, J., Greenhouse, J. J., Brennan, T. P., Jiang, J. B., VanCott, T. C., Lu, Y., Eddy, G. A., Birx, D. L. (1999). Limited Protection from a Pathogenic Chimeric Simian-Human Immunodeficiency Virus Challenge following Immunization with Attenuated Simian Immunodeficiency Virus. J. Virol. 73: 1262-1270 [Abstract] [Full Text]  
  • Pauza, C. D., Trivedi, P., Wallace, M., Ruckwardt, T. J., Le Buanec, H., Lu, W., Bizzini, B., Burny, A., Zagury, D., Gallo, R. C. (2000). Vaccination with Tat toxoid attenuates disease in simian/HIV-challenged macaques. Proc. Natl. Acad. Sci. USA 97: 3515-3519 [Abstract] [Full Text]